[Established and new therapeutic approaches in dermatomyositis, polymyositis and overlapping syndromes].
An overview is presented on current antiinflammatory, cytostatic/cytotoxic and immunomodulatory treatments for immunologically mediated inflammatory myopathies with skin involvement. High-dose intravenous immunoglobulin (IVIG) therapy is discussed in the context of recent findings regarding pathogenic mechanisms of autoimmune diseases.
Göttfried
I
I
Abteilung für Immundermatologie und Infektiöse Hautkrankheiten, Universität Wien.
Seeber
A
A
Anegg
B
B
Pirkhammer
D
D
Rieger
A
A
Stingl
G
G
Volc-Platzer
B
B
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001781:Blood Component Removal; D003131:Combined Modality Therapy; D003882:Dermatomyositis / Q000276:immunology / Q000628:therapy*; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D007116:Immunization, Passive; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D017893:Photopheresis; D017285:Polymyositis / Q000276:immunology / Q000628:therapy*; D013256:Steroids
D000893:Anti-Inflammatory Agents; D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D013256:Steroids
Etablierte und neue Therapiestrategien bei Dermatomyositis, Polymyositis und Uberlappungssyndromen.